--- title: "Tesamorelin + Ipamorelin: what sources report" url: https://humanpeptides.fyi/peptides/tesamorelin-ipamorelin site: humanpeptides.fyi last_reviewed: 2026-10-11 --- # Tesamorelin + Ipamorelin > humanpeptides.fyi makes no claims of its own. Every statement below reports what a cited source says, with its link. Not medical advice. Tesamorelin + Ipamorelin: Combination of tesamorelin (GHRH analogue, FDA-approved Egrifta for HIV visceral fat) and ipamorelin (selective ghrelin-receptor GH secretagogue, not FDA-approved). The sources cited here most often discuss it for: Synergistic GH release, theoretical; Belly fat, via tesamorelin; Deeper sleep, anecdotal. Evidence label: Unstudied. ## At a glance - **Type:** Blend - **Family:** Growth Hormone Axis - **Evidence label:** Unstudied (1 of 5) - **Regulatory status:** Dr. Axe's A-Z guide lists tesamorelin as FDA-approved for a specific HIV-related belly fat condition, while it lists ipamorelin, paired with CJC-1295, as research only and not FDA-approved. - **Goals discussed:** Hormones & Fertility, Fat Loss & Metabolism, Heart, Liver & Kidney, Sleep - **Also called:** Egrifta WR, Egrifta SV, tesamorelin acetate, Ipamorelin acetate, Tesa, IPA, Tesamorelin/Ipamorelin - **Last reviewed:** 2026-10-11 ## What is Tesamorelin + Ipamorelin? - Combination of tesamorelin (GHRH analogue, FDA-approved Egrifta for HIV visceral fat) and ipamorelin (selective ghrelin-receptor GH secretagogue, not FDA-approved); intent is synergistic endogenous GH/IGF-1 release via two receptor pathways; the blend itself has never been studied. Sources: , Tesamorelin (Egrifta) is a GHRH analog distinct from sermorelin and CJC-1295; ipamorelin is more often paired with CJC-1295, and the tesamorelin pairing is a separate, unstudied combination. **Regulatory status:** Dr. Axe's A-Z guide lists tesamorelin as FDA-approved for a specific HIV-related belly fat condition, while it lists ipamorelin, paired with CJC-1295, as research only and not FDA-approved. Source: ## What is Tesamorelin + Ipamorelin researched for? ### 1. Synergistic GH release, theoretical - Synergistic GH release: GHRH plus a GHRP produced more GH than the sum of either alone in healthy men (human study with GHRP, not ipamorelin/tesamorelin specifically) Sources: , - Goals: [Hormones & Fertility](https://humanpeptides.fyi/objectives/hormones) ### 2. Belly fat, via tesamorelin - See Tesamorelin: visceral fat reduction (FDA-approved in HIV), liver fat and cognition data (human RCTs) Sources: , - Goals: [Fat Loss & Metabolism](https://humanpeptides.fyi/objectives/fat-loss), [Heart, Liver & Kidney](https://humanpeptides.fyi/objectives/organs) ### 3. Deeper sleep, anecdotal - Users report faster/deeper sleep and vivid dreams within days-2 weeks, better recovery, and midsection fat loss after ~6-12 weeks (anecdotal Reddit/forum) Sources: , , - Goals: [Sleep](https://humanpeptides.fyi/objectives/sleep) ## What do researchers and users say about Tesamorelin + Ipamorelin? > "A study published in literature identified serious adverse events including death when ipamorelin was administered intravenously for improving gastric motility." > > US Food and Drug Administration, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Context: FDA safety summary for ipamorelin acetate, still in 503B category 2; the events involved intravenous use for gastric motility, and FDA says it lacks safety data for other injection routes. > "The effects of prolonged elevations in IGF-1 levels are unknown." > > Theratechnologies, EGRIFTA WR prescribing information, Label: EGRIFTA WR- tesamorelin kit (DailyMed). Context: Warning in the US label for tesamorelin, which raises growth hormone and IGF-1. > "Sleeps been phenomenal, and my belly fat is being assassinated." > > Anonymous user, r/BodyHackGuide, Does Tesamorelin/Ipamorelin work this fast or is it placebo?. Context: Forum reply from a user of a tesamorelin and ipamorelin blend; others in the thread report water retention and carpal tunnel symptoms. ## What side effects of Tesamorelin + Ipamorelin are reported? - Water retention, bloating, injection-site pain, occasional histamine-like reactions (anecdotal) Sources: - Tesamorelin label risks: arthralgia, edema, carpal tunnel, glucose intolerance, malignancy caution Sources: - Hypersensitivity reactions such as itching, redness, flushing, hives and rash occurred in 4% of tesamorelin-treated patients in trials. (FDA label) Sources: - About half of patients in tesamorelin trials developed anti-tesamorelin antibodies. (FDA label) Sources: - Growth hormone at pharmacologic levels has been linked to increased mortality in acutely critically ill patients, and the tesamorelin label advises considering discontinuation in that setting. (FDA label) Sources: - Tesamorelin is contraindicated in pregnancy because it could cause fetal harm. (FDA label) Sources: - Possible immunogenicity from aggregation or impurities in compounded ipamorelin; serious adverse events including death were reported with intravenous ipamorelin. (FDA assessment) Sources: ## What do peptide guides say about Tesamorelin + Ipamorelin? - **Dr. Axe:** Dr. Axe's library notes tesamorelin is approved only for HIV-associated abdominal fat, not general weight loss, with contraindications including active malignancy and pregnancy, and glucose and IGF-1 monitoring advised. - **Dr. Axe:** Dr. Axe points out that the World Anti-Doping Agency list includes growth hormone-releasing peptides such as ipamorelin and tesamorelin, so tested athletes risk sanctions. - **PepEdHub:** PepEdHub says tesamorelin is often combined with ipamorelin to boost GH release, and advises monitoring IGF-1, glucose and HbA1c during therapy. - **PepEdHub:** PepEdHub describes ipamorelin as a selective ghrelin-receptor agonist with little effect on cortisol or prolactin, listing water retention, tingling in the extremities and increased hunger as possible effects. - **Seek Peptides:** Seek Peptides presents ipamorelin plus tesamorelin as a visceral-fat pairing, with ipamorelin adding complementary GH stimulation, offered as a rationale rather than a tested protocol. ## What does the research say, system by system? ### Body & tissues - Visceral fat and liver (tesamorelin component, human RCTs) )30338-8/abstract Sources: ### Hormones & physiology - Ipamorelin releases GH without significantly raising ACTH/cortisol (animal) Sources: - Tesamorelin raises IGF-1 and may impair glucose tolerance (FDA label) Sources: ### Brain, mood & sleep - Sleep improvement widely reported (anecdotal) Sources: - Tesamorelin improved executive function in older adults (human RCT) Sources: ### Weight & metabolism - Visceral fat reduction via tesamorelin component (human RCTs) Sources: - Blend not proven superior to tesamorelin alone (Reddit discussion) Sources: ### Muscle - Tesamorelin increased lean mass in HIV trials Sources: - No human muscle data for ipamorelin; its only phase 2 trial (postoperative ileus) failed Sources: ### Also notable - Users often inject components separately rather than pre-mixed (anecdotal) Sources: ## How strong is the evidence for Tesamorelin + Ipamorelin? **Unstudied** (1 of 5). Blend unstudied; tesamorelin has strong human data, ipamorelin mostly animal; GHRH+GHRP synergy shown in older human physiology studies; blend benefits anecdotal _No direct studies of this product or blend. Anecdote and component data only._ ## Questions about Tesamorelin + Ipamorelin ### What is Tesamorelin + Ipamorelin? Combination of tesamorelin (GHRH analogue, FDA-approved Egrifta for HIV visceral fat) and ipamorelin (selective ghrelin-receptor GH secretagogue, not FDA-approved). Tesamorelin (Egrifta) is a GHRH analog distinct from sermorelin and CJC-1295; ipamorelin is more often paired with CJC-1295, and the tesamorelin pairing is a separate, unstudied combination. ### Is Tesamorelin + Ipamorelin FDA-approved? Dr. Axe's A-Z guide lists tesamorelin as FDA-approved for a specific HIV-related belly fat condition, while it lists ipamorelin, paired with CJC-1295, as research only and not FDA-approved. ### What is Tesamorelin + Ipamorelin researched for? The sources cited on this page most often discuss three outcomes: Synergistic GH release, theoretical; Belly fat, via tesamorelin; Deeper sleep, anecdotal. Each line above shows what the source reports and how strong that evidence is. ### What side effects of Tesamorelin + Ipamorelin are reported? Reported in the cited sources: Water retention, bloating, injection-site pain, occasional histamine-like reactions; Tesamorelin label risks: arthralgia, edema, carpal tunnel, glucose intolerance, malignancy caution; Hypersensitivity reactions such as itching, redness, flushing, hives and rash occurred in 4% of tesamorelin-treated patients in trials. The list is not complete, and few listed risks does not mean a compound is safe. ### How strong is the evidence for Tesamorelin + Ipamorelin? Evidence label: Unstudied. Blend unstudied; tesamorelin has strong human data, ipamorelin mostly animal; GHRH+GHRP synergy shown in older human physiology studies; blend benefits anecdotal. ### What else is Tesamorelin + Ipamorelin called? Names used for it include Egrifta WR, Egrifta SV, tesamorelin acetate, Ipamorelin acetate, Tesa, IPA, Tesamorelin/Ipamorelin. ### Does humanpeptides.fyi recommend Tesamorelin + Ipamorelin? No. humanpeptides.fyi makes no claims and no recommendations of its own. It summarizes and links to what others have published and posted. Nothing here is medical advice; talk to a licensed clinician. --- Family: [Growth Hormone Axis](https://humanpeptides.fyi/peptides?cat=gh-axis). HTML version: . Disclaimer: